UTILITY Therapeutics
Rasmus Toft-Kehler is the CEO of AntibioTx and the co-founder and board member of multiple biotech companies. Prior to entering biotech, Rasmus worked with M&A (Goldman Sachs and Gudme Raaschou), management consulting (Booz Allen Hamilton), and as a board member of a family-owned enterprise until it was successfully sold in 2005. Rasmus holds a business degree from New York University and Copenhagen Business School and an executive degree from Harvard Business School. Rasmus is the inventor of 5+ patents and is currently completing a quantitative PhD on serial entrepreneurship. His research has been published in leading scientific and entrepreneurship journals such as Nature Reviews Microbiology and the Journal of Business Venturing. In 2007, Rasmus led a team of four inexperienced sailors to successfully cross the Pacific Ocean.
This person is not in the org chart
This person is not in any offices
UTILITY Therapeutics
UTILITY Therapeutics Ltd., is a biotechnology company focused on the U.S. development and commercialization of two European-approved antibiotics for the treatment of urinary tract infections (UTI), to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections.